MEX3A and cervical carcinoma: In addition, upregulation of MEX3A was associated with shorter overall survival only in patients with HPV-negative cervical cancer, implying that MEX3A is not only related to the occurrence of HPV-negative cervical but also to prognosis of HPV-negative cervical cancer.